专题：Spondyloarthritis Studies and Treatments

This cluster of papers focuses on the classification, diagnosis, and treatment of spondyloarthritis, including ankylosing spondylitis and psoriatic arthritis. It covers the development of new classification criteria, assessment of disease activity, use of biologic therapies such as tumor necrosis factor inhibitors and interleukin-17 inhibitors, and the impact of genetic factors like HLA-B27.
最新文献
EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2023 update

review Full Text OpenAlex

Matching-Adjusted Indirect Comparison of the 52-Week Efficacy of Bimekizumab Versus Secukinumab and Ixekizumab for the Treatment of Radiographic Axial Spondyloarthritis

article Full Text OpenAlex

Effect of bimekizumab on patient-reported disease impact in patients with psoriatic arthritis: 1-year results from two phase 3 studies

article Full Text OpenAlex

Ultrasonographic Insights into Peripheral Psoriatic Arthritis: Updates in Diagnosis and Monitoring

article Full Text OpenAlex

Safety and effectiveness of apremilast in Japanese patients with psoriatic disease: Results of a post‐marketing surveillance study

article Full Text OpenAlex

Natural language processing to identify and characterize spondyloarthritis in clinical practice

article Full Text OpenAlex

Extraarticular manifestations of juvenile idiopathic arthritis and their impact on health-related quality of life

article Full Text OpenAlex

Cardiovascular Risk Evaluation in Psoriatic Arthritis by Aortic Stiffness and the Systemic Coronary Risk Evaluation (SCORE): Results of the Prospective PSOCARD Cohort Study

article Full Text OpenAlex

Regional Differences in Diagnosis Journey and Healthcare Utilization: Results from the International Map of Axial Spondyloarthritis (IMAS)

article Full Text OpenAlex

Durable control of psoriatic arthritis with guselkumab across domains and patient characteristics: post hoc analysis of a phase 3 study

article Full Text OpenAlex

近5年高被引文献
ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update

article Full Text OpenAlex 751 FWCI188.50984475

Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA): updated treatment recommendations for psoriatic arthritis 2021

review Full Text OpenAlex 512 FWCI128.60952025

EULAR recommendations for cardiovascular risk management in rheumatic and musculoskeletal diseases, including systemic lupus erythematosus and antiphospholipid syndrome

article Full Text OpenAlex 317 FWCI79.53152329

Ankylosing spondylitis: an autoimmune or autoinflammatory disease?

review Full Text OpenAlex 316 FWCI55.84419291

Axial spondyloarthritis

review Full Text OpenAlex 293 FWCI47.47886847

Psoriatic arthritis

review Full Text OpenAlex 282 FWCI31.93285622

Trial of Upadacitinib and Adalimumab for Psoriatic Arthritis

article Full Text OpenAlex 268 FWCI46.80059892

EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2023 update

review Full Text OpenAlex 233 FWCI241.37539478

Association Between Psoriasis and Nonalcoholic Fatty Liver Disease Among Outpatient US Adults

article Full Text OpenAlex 230 FWCI27.04338535

Tofacitinib for the treatment of ankylosing spondylitis: a phase III, randomised, double-blind, placebo-controlled study

article Full Text OpenAlex 228 FWCI41.60053237